Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2009 October;100(5): > Minerva Medica 2009 October;100(5):415-20

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  OVARIAN CANCER 

Minerva Medica 2009 October;100(5):415-20

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

PET/CT scans in ovarian cancer: prognostic versus predictive utility?

Markman M.

Department of Gynecologic Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA


PDF


The use of PET/CT has been advocated in the management of ovarian cancer as a diagnostic strategy to assist in patient management. To date, data in the peer reviewed literature support the argument that findings on PET/CT reveal evidence of the extent of disease and may be helpful in documenting disease recurrence. However, it remains to be determined through the conduct of phase 3 randomized trials if the information generated will be useful in predicting benefit of a management plan specifically selected based on the results of this expensive radiographic procedure.

top of page